Stocksigma LogoStocksigma Logo

Q-Line Biotech Schedules Board Meeting on 12th Nov'26 to Approve H1 Financial Results

Q-Line Biotech Limited has scheduled its Board of Directors meeting on 12th Nov'26 at 04:15 p.m. to consider and approve the unaudited standalone and

Q-Line Biotech Schedules Board Meeting on 12th Nov'26 to Approve H1 Financial Results

Q-Line Biotech Ltd 路 Others (Uncategorized) 路 06 Nov 2026, 12:40 am

Q-Line Biotech Schedules Board Meeting on 12th Nov'26 to Approve H1 Financial Results Q-Line Biotech Limited has scheduled its Board of Directors meeting on 12th Nov'26 at 04:15 p.m. to consider and approve the unaudited standalone and consolidated financial results, Statement of Assets and Liabilities, and Cash Flow statement for the half-year ended 30th Sep'26, along with the Statutory Auditor's Limited Review Reports. The company also issued a clarification confirming the meeting will occur at 4:15 p.m., rectifying an inadvertent clerical error that previously stated 3:00 p.m. in the subject line.

Original exchange filing (PDF)

More announcements from Q-Line Biotech Ltd

All Q-Line Biotech Ltd announcements